STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells |
Jang, Hui-Ju
(Department of Bioscience and Biotechnology, Konkuk University)
Bak, Yesol (Department of Bioscience and Biotechnology, Konkuk University) Pham, Thu-Huyen (Department of Bioscience and Biotechnology, Konkuk University) Kwon, Sae-Bom (Department of Bioscience and Biotechnology, Konkuk University) Kim, Bo-Yeon (World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology) Hong, JinTae (College of Pharmacy and Medical Research Center, Chungbuk National University) Yoon, Do-Young (Department of Bioscience and Biotechnology, Konkuk University) |
1 | Siegel R, Naishadham D and Jemal A (2012) Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 62, 283-298 DOI |
2 | Lozano R, Naghavi M, Foreman K et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380, 2095-2128 DOI |
3 | Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D (2011) Global cancer statistics. CA Cancer J Clin 61, 69-90 DOI |
4 | Bak Y, Kwon T, Bak IS, Hong J, Yu DY and Yoon DY (2016) IL-32theta inhibits stemness and epithelialmesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer. Oncotarget 7, 7307-7317 |
5 | Merika E, Saif MW, Katz A, Syrigos K and Morse M (2010) Review. Colon cancer vaccines: an update. In Vivo 24, 607-628 |
6 | Bonnet D and Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737 DOI |
7 | Jordan CT (2009) Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 4, 203-205 DOI |
8 | Lessard J and Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423, 255-260 DOI |
9 | Lee HE, Kim JH, Kim YJ et al (2011) An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer 104, 1730-1738 DOI |
10 | Gao XM, Zhang R, Dong QZ and Qin LX (2016) Properties and feasibility of using cancer stem cells in clinical cancer treatment. Cancer Biol Med 13, 489-495 DOI |
11 | Vinogradov S and Wei X (2012) Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) 7, 597-615 DOI |
12 | Jordan MA and Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4, 253-265 DOI |
13 | Zhou J and Giannakakou P (2005) Targeting microtubules for cancer chemotherapy. Curr Med Chem Anticancer Agents 5, 65-71 DOI |
14 | Sakchaisri K, Kim SO, Hwang J et al (2017) Anticancer activity of a novel small molecule tubulin inhibitor STK899704. PLoS One 12, e0173311 DOI |
15 | Gialeli C, Theocharis AD and Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278, 16-27 DOI |
16 | Liang W, Lai Y, Zhu M, Huang S, Feng W and Gu X (2016) Combretastatin A4 regulates proliferation, migration, invasion, and apoptosis of thyroid cancer cells via PI3K/Akt signaling pathway. Med Sci Monit 22, 4911-4917 DOI |
17 | McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5, 505-515 DOI |
18 | Goldman RD (1971) The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine. J Cell Biol 51, 752-762 DOI |
19 | Pastrana E, Silva-Vargas V and Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8, 486-498 DOI |
20 | Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988 DOI |
21 | Han YS, Lee JH and Lee SH (2015) Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways. Mol Med Rep 12, 3446-3452 DOI |
22 | Mu Y, Zou H, Chen B, Fan Y and Luo S (2017) FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway. Biomed Pharmacother 90, 548-554 DOI |
23 | Wang YJ, Zhang ZF, Fan SH et al (2017) MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK. Oncotarget 8, 100227-100241 |
24 | Suva ML, Riggi N, Stehle JC et al (2009) Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 69, 1776-1781 DOI |
25 | Deramaudt TB, Dujardin D, Noulet F et al (2014) Altering FAK-paxillin interactions reduces adhesion, migration and invasion processes. PLoS One 9, e92059 DOI |
26 | Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF and Giancotti FG (2009) Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119, 252-266 |
27 | Schlaepfer DD, Mitra SK and Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692, 77-102 DOI |
28 | Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T and Moriwaki H (2006) Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 351, 820-824 DOI |
29 | Kim WT and Ryu CJ (2017) Cancer stem cell surface markers on normal stem cells. BMB Rep 50, 285-298 DOI |
30 | Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB and Farrar WL (2008) CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98, 756-765 DOI |
31 | Bak Y, Kang JW, Kim MS et al (2014) IL-32theta downregulates CCL5 expression through its interaction with PKCdelta and STAT3. Cell Signal 26, 3007-3015 DOI |
32 | Bak Y, Ham S, Baatartsogt O et al (2013) A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways. Mol Biol Rep 40, 4507-4519 DOI |